| Style | Citing Format |
|---|---|
| MLA | Hosseinzadeh Adli A, Baghban Rahimi S. "Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.”." Biomedicine and Pharmacotherapy, vol. 153, no. , 2022, pp. -. |
| APA | Hosseinzadeh Adli A, Baghban Rahimi S (2022). Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.”. Biomedicine and Pharmacotherapy, 153(), -. |
| Chicago | Hosseinzadeh Adli A, Baghban Rahimi S. "Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.”." Biomedicine and Pharmacotherapy 153, no. (2022): -. |
| Harvard | Hosseinzadeh Adli A, Baghban Rahimi S (2022) 'Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.”', Biomedicine and Pharmacotherapy, 153(), pp. -. |
| Vancouver | Hosseinzadeh Adli A, Baghban Rahimi S. Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.”. Biomedicine and Pharmacotherapy. 2022;153():-. |
| BibTex | @article{ author = {Hosseinzadeh Adli A and Baghban Rahimi S}, title = {Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.”}, journal = {Biomedicine and Pharmacotherapy}, volume = {153}, number = {}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Hosseinzadeh Adli A AU - Baghban Rahimi S TI - Comment on “Covid-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality.” JO - Biomedicine and Pharmacotherapy VL - 153 IS - SP - EP - PY - 2022 ER - |